Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-24

Clinical Trial Update: Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing QoR-15 scores after laparoscopic cholecystectomy using sugammadex versus neostigmine for neuromuscular blockade reversal has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)
  • Sugammadex (sugammadex)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Neuromuscular Blockade Reversal Agent, Sugammadex | Phase 4 | Status: COMPLETED